263 related articles for article (PubMed ID: 20425794)
21. Avascular necrosis--an antineoplastic-treatment-related toxicity: the experiences of two institutions.
Sawicka-Zukowska M; Kajdas L; Muszynska-Roslan K; Krawczuk-Rybak M; Sonta-Jakimczyk D; Szczepanski T
Pediatr Hematol Oncol; 2006 Dec; 23(8):625-9. PubMed ID: 17065138
[TBL] [Abstract][Full Text] [Related]
22. Altered endothelial function following the Fontan procedure.
Binotto MA; Maeda NY; Lopes AA
Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
[TBL] [Abstract][Full Text] [Related]
23. L-Asparaginase and the effect of age on coagulation and fibrinolysis in childhood acute lymphoblastic leukemia.
Appel IM; Hop WC; van Kessel-Bakvis C; Stigter R; Pieters R
Thromb Haemost; 2008 Aug; 100(2):330-7. PubMed ID: 18690355
[TBL] [Abstract][Full Text] [Related]
24. Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000.
Attarbaschi A; Mann G; Kronberger M; Witt V; Gadner H; Dworzak M
Klin Padiatr; 2003; 215(6):321-6. PubMed ID: 14677096
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
[TBL] [Abstract][Full Text] [Related]
26. Herpes simplex virus reactivation and disease during treatment for childhood acute lymphoblastic leukemia.
Lauten M; Güttel C; Härtel C; Erdlenbruch B
Klin Padiatr; 2014 May; 226(3):188-9. PubMed ID: 24158893
[No Abstract] [Full Text] [Related]
27. Evaluation of renal function in Turkish children receiving BFM-95 therapy for acute lymphoblastic leukemia.
Kaya Z; Gursel T; Bakkaloglu SA; Kocak U; Atasever T; Oktar SO
Pediatr Hematol Oncol; 2007 Jun; 24(4):257-67. PubMed ID: 17613868
[TBL] [Abstract][Full Text] [Related]
28. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
[TBL] [Abstract][Full Text] [Related]
29. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
[TBL] [Abstract][Full Text] [Related]
30. Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS).
Watanabe R; Murata M; Takayama N; Tokuhira M; Kizaki M; Okamoto S; Kawai Y; Watanabe K; Murakami H; Kikuchi M; Nakamura S; Ikeda Y
Thromb Haemost; 1997 Apr; 77(4):641-5. PubMed ID: 9134635
[TBL] [Abstract][Full Text] [Related]
31. Thrombotic effects of asparaginase in two acute lymphoblastic leukemia protocols (NOPHO ALL-1992 versus NOPHO ALL-2000): a single-institution study.
Ruud E; Holmstrøm H; de Lange C; Natvig S; Albertsen BK; Wesenberg F
Pediatr Hematol Oncol; 2006; 23(3):207-16. PubMed ID: 16517537
[TBL] [Abstract][Full Text] [Related]
32. Hypercoagulability existing in the local left atrium of patient with mitral stenosis.
Wang J; Xie X; He H; Huang J; Lu D; Yang Q
Chin Med J (Engl); 2003 Aug; 116(8):1198-202. PubMed ID: 12935411
[TBL] [Abstract][Full Text] [Related]
33. Children with acute lymphoblastic leukemia: is there any subgroup of children without elevated thrombin generation? A preliminary study utilizing measurements of thrombin-antithrombin III complexes.
Uszyński M; Osińska M; Zekanowska E; Ziółkowska E
Med Sci Monit; 2000; 6(1):108-11. PubMed ID: 11208295
[TBL] [Abstract][Full Text] [Related]
34. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.
Ishii E; Eguchi H; Matsuzaki A; Koga H; Yanai F; Kuroda H; Kawakami K; Ayukawa H; Akiyoshi K; Kamizono J; Tamai Y; Kinukawa N; Okamura J
Med Pediatr Oncol; 2001 Jul; 37(1):10-9. PubMed ID: 11466717
[TBL] [Abstract][Full Text] [Related]
35. [The programmed therapy of acute lymphoblastic leukemia in adults].
Isaev VG; Savchenko VG; Kucher RA; Abakumov EM; Parovichnikova EN
Ter Arkh; 1992; 64(8):82-7. PubMed ID: 1440405
[No Abstract] [Full Text] [Related]
36. Changes in antithrombin and fibrinogen levels during induction chemotherapy with L-asparaginase in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma. Use of supportive coagulation therapy and clinical outcome: the CAPELAL study.
Hunault-Berger M; Chevallier P; Delain M; Bulabois CE; Bologna S; Bernard M; Lafon I; Cornillon J; Maakaroun A; Tizon A; Padrazzi B; Ifrah N; Gruel Y;
Haematologica; 2008 Oct; 93(10):1488-94. PubMed ID: 18728028
[TBL] [Abstract][Full Text] [Related]
37. Alterations in procoagulant, anticoagulant, and fibrinolytic systems before and after start of induction chemotherapy in children with acute lymphoblastic leukemia.
Albayrak M; Gürsel T; Kaya Z; Koçak U
Clin Appl Thromb Hemost; 2013; 19(6):644-51. PubMed ID: 22751908
[TBL] [Abstract][Full Text] [Related]
38. Hemostatic changes in children with acute lymphoblastic leukemia treated according to two different L-asparaginase schedules.
Miniero R; Pastore G; Saracco P; Messina M; Lange MM; Fiandino G; Iannacci L; Madon E
Am J Pediatr Hematol Oncol; 1986; 8(2):116-20. PubMed ID: 3461716
[TBL] [Abstract][Full Text] [Related]
39. Acute lymphoblastic leukemia: dental health of children in maintenance therapy.
Sepet E; Aytepe Z; Ozerkan AG; Yalman N; Guven Y; Anak S; Devecioglu O; Agaoglu L; Gedikoglu G
J Clin Pediatr Dent; 1998; 22(3):257-60. PubMed ID: 9641104
[TBL] [Abstract][Full Text] [Related]
40. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
Matsuzaki A; Ishii E; Okamura J; Eguchi H; Yoshida N; Yanai F; Inoue T; Miyake K; Ishihara T; Tsuboi C
Med Pediatr Oncol; 1996 Jan; 26(1):10-9. PubMed ID: 7494507
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
